CBondlogo-Red.png
C-Bond Systems to File its Form 10-K on April 1, 2024, and Hold Conference Call to Discuss its Financial Results on April 3, 2024
March 29, 2024 08:30 ET | C-Bond Systems
SAN ANTONIO, March 29, 2024 (GLOBE NEWSWIRE) -- C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, announced today...
Discovery Silver Logo.png
Discovery Reports Fourth Quarter and Full-Year 2023 Financial Results
March 28, 2024 21:47 ET | Discovery Silver Corp.
TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced financial results for the three and twelve months ended...
A91rwy24l_1p300ls_gm4.png
Lowell Farms Inc. Announces Audited Fourth Quarter and Fiscal Year 2023 Financial and Operational Results
March 28, 2024 08:00 ET | Lowell Farms Inc.
SALINAS, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities...
Caledonia-gr.jpg
Caledonia Mining Corporation Plc Results for the Year ended December 31, 2023; Notice of Management Conference Call; Dividend Declaration
March 28, 2024 03:00 ET | Caledonia Mining Corporation Plc
ST HELIER, Jersey, March 28, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces its operating and...
Logo.png
Healthier Choices Management Corp. Reports Fourth Quarter 2023 Financial Results and Full Year Fiscal 2023 Results
March 27, 2024 17:00 ET | Healthier Choices Management Corp
-Fourth Quarter Sales of $15.9 Million, Up 29%, and Gross Profit of $5.7 Million, up 41%, over Q4 2022 -Full Year Sales of $55.7 Million, Up 90%, and Gross Profit of $20.3 Million Up 99%; over 2022...
Celcuity+Logo.jpg
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 27, 2024 16:01 ET | Celcuity Inc.
Dosed the first patient in a Phase 1b/2 trial evaluating gedatolisib in combination with darolutamide for the treatment of metastatic castration resistant prostate cancer Presented nonclinical data...
SCU_Stacked_CMYK.jpg
Servus begins fiscal year with strong financial performance and growth
March 27, 2024 09:56 ET | Servus Credit Union
Servus Credit Union continued its strong growth trend with assets reaching $20.6 billion, up $1.8 billion (9.8%), compared to the first quarter of 2023.
sunlands logo.jpg
Sunlands Technology Group Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results
March 22, 2024 04:30 ET | Sunlands Technology Group
BEIJING, March 22, 2024 (GLOBE NEWSWIRE) -- Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s online post-secondary and professional education, today announced...
Celcuity+Logo.jpg
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
March 20, 2024 07:05 ET | Celcuity Inc.
MINNEAPOLIS, March 20, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it...
BioNTech Announces F
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
March 20, 2024 06:15 ET | BioNTech SE
  Advanced oncology pipeline in mid- and late-stage with plans to have ten or more potentially registrational oncology trials running by the end of 2024Aiming for first oncology launch in 2026 and...